Can below-optimal vitamin D impair immune tolerance and relate to thyroid autoimmunity?

Active vitamin D serves as a key endocrine regulator of immune tolerance, and its insufficiency is closely tied to the pathogenesis of thyroid autoimmunity.

Mechanistic pathways

• Loss of Treg stability: Active vitamin D binds to the vitamin D receptor (VDR) on $CD4^+$ T cells, heterodimerizing with the retinoid X receptor to bind vitamin D response elements. This process directly drives the transcription of FOXP3—the master controller of regulatory T-cell (Treg) identity—as well as Helios, CTLA-4, and the anti-inflammatory cytokine IL-10. Below-optimal levels restrict VDR occupancy, impairing FOXP3 expression and IL-10 production, which compromises Treg suppressive capacity.
• Altered antigen presentation: Vitamin D deficiency disrupts the generation of tolerogenic dendritic cells (characterized by low MHC-II and high IL-10), shifting the immune microenvironment toward pathogenic Th1 and Th17 pathways and increasing inflammatory cytokines.

Clinical and thyroid-specific evidence

• Thyroid autoimmunity: Clinical and epidemiological studies show that serum 25-hydroxyvitamin D levels below 20 ng/mL are independently associated with higher odds of autoimmune thyroid disease, such as Hashimoto's thyroiditis.
• TPOAb reductions: Deficient status strongly correlates with elevated thyroid peroxidase antibody (TPOAb) titers. However, targeting this deficiency with 3 to 6 months of cholecalciferol (vitamin D3) supplementation consistently and significantly lowers TPOAb levels.

Bottom line

• Sub-optimal vitamin D status impairs immune tolerance by restricting VDR-dependent transcriptional programs critical for Treg function, directly contributing to thyroid autoimmunity and high TPOAb levels, both of which can be clinically improved through targeted vitamin D3 supplementation.